For thymic carcinoma, the novel biomarkers of MSLN, CCL20, and SLC1A5 are identified and observed an elevated expression of LAG3 and HAVCR2 in malignant tumorn‐infiltrating mature T cells. This evidence concerns the gene MSLN and thymic carcinoma.